Ratings
0
Nobody has rated this yet. Be the first!
Works
3
Safety and tolerability of nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from the SENSCIS trial
Transcriptome analysis of IPF fibroblastic foci identifies key pathways involved in fibrogenesis
Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosis
